Zeneca Farma

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company operates across several main disease areas, including Oncology, Cardiovascular, Renal & Metabolism (CVRM), and Respiratory & Immunology. Formed through the 1999 merger of the Swedish company Astra AB and the British company Zeneca Group, it has a robust pipeline and a significant global footprint. AstraZeneca is well-known for its COVID-19 vaccine and blockbuster drugs like Tagrisso, Farxiga, and Imfinzi. The company has recently expanded its portfolio into rare diseases through the acquisition of Alexion Pharmaceuticals. AstraZeneca continues to invest heavily in R&D, focusing on innovative modalities such as antibody-drug conjugates and cell therapies.